共 50 条
Synthesis, X-ray crystal structure, Hirshfeld combined with DFT and anticancer efficacy of (Z)-N-methyl-C-aryl aldonitrones
被引:0
作者:
Lasri, Jamal
[1
]
Soliman, Saied M.
[2
]
Ali, Ehab M. M.
[3
,4
]
Eltayeb, Naser E.
[1
,5
]
Dege, Necmi
[6
]
Alzahrani, Faisal Ay.
[7
]
机构:
[1] King Abdulaziz Univ, Rabigh Coll Sci & Arts, Dept Chem, Jeddah 21589, Saudi Arabia
[2] Alexandria Univ, Fac Sci, Dept Chem, Alexandria, Egypt
[3] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia
[4] Tanta Univ, Fac Sci, Dept Chem, Tanta 31527, Egypt
[5] Int Univ Africa, Fac Pure & Appl Sci, Dept Chem, Khartoum, Sudan
[6] Ondokuz Mayis Univ, Fac Arts & Sci, Dept Phys, TR-55139 Samsun, Turkiye
[7] King Abdulaziz Univ, Dept Chem, Coll Sci & Arts, Rabigh 21911, Saudi Arabia
关键词:
(Z)-N-methyl-C-aryl aldonitrones;
X-ray single crystal;
DFT;
Hirshfeld;
Anticancer;
MOLECULAR-STRUCTURE;
NITRONES;
COMPLEXES;
MODEL;
D O I:
10.1016/j.molstruc.2024.138699
中图分类号:
O64 [物理化学(理论化学)、化学物理学];
学科分类号:
070304 ;
081704 ;
摘要:
( Z )- N -methyl- C -aryl aldonitrones - O + N (Me) =C(H)R ( 1 R = 2-naphthyl, 2 R = 2-hydroxy-1-naphthyl, 3 R = 1naphthyl, 4 R = 2-hydroxyphenyl) were synthesised and fully characterised by several methods. The supramolecular structure aspects of 1 and 2 were analysed utilizing Hirshfeld topology analysis. In 1 , the most common contacts are the H ... H (45.1 %), C ... H (39.1 %) and O ... H (13.0 %) interactions while the corresponding values in case of 2 are 47.7, 24.0 and 18.8 %, respectively. The C ... H and O ... H interactions have the characteristic features of short important contacts in 1 while only the O ... H interaction is the most significant in case of 2 . Based on DFT calculations, the HOMO, LUMO, natural charges, polarity as well as chemical reactivity descriptors were predicted and compared for both compounds. On the other hand, compounds 1 - 4 reduced the growth of MCF-7 and T47D. Compound 3 , which has the lowest IC 50 values against the MCF-7 and T47D cell lines, is thought to be the most promising applicant as an anticancer drug.
引用
收藏
页数:14
相关论文